BioSpace News Archive

Ormco Corporation announces the highly anticipated Spark Clear Aligners Release 14. Release 14 continues Spark’s philosophy of giving orthodontists control and flexibility.

Chiesi USA, Inc., a Cary-based specialty pharmaceutical company, announced that Chiesi Group is continuing to experience major growth this year.

Alpha Pro Tech, Ltd., a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, announced financial results for the three and six month periods ended June 30, 2023.

NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, has received Institutional Review Board (IRB) approval for its landmark Phase 1b/2a proof-of-concept clinical trial protocol of its proprietary lead compound, NVG-291, in individuals with spinal cord injury (SCI).

Nephron 503B Outsourcing Facility, a division of Nephron Pharmaceuticals Corporation, is focused on resolving drug shortage concerns with the production of 0.5% Albuterol 5 mL, del Nido Cardioplegia, Lidocaine 1% and Succinylcholine products.

Hydromer, Inc. (OTC: HYDI) today announced the resignation of all its board of directors. There were no disagreements between the Company and the board of directors. The company has swiftly acted to ensure continuity and has appointed new members to its board of directors.

EmitBio Inc. is excited to announce its participation in the World Congress on Infectious Diseases, scheduled to take place from October 23 to 25, 2023 in Boston, Massachusetts.

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced a key opinion leader roundtable discussion to be held on Friday, August 11, 2023, 8:00 a.m. – 9:00 a.m. ET to discuss the latest data from the ReSPECT-LM clinical trial of rhenium (186Re) obisbemeda that will be presented at the Society for Neuro Oncology (SNO)/American Society of Clinical Oncology (ASCO) Central Nervous System (CNS) Cancer Conference on August 10, 2023.

Medtronic plc, a global leader in healthcare technology, announced that it will report financial results for its first quarter of fiscal year 2024 on Tuesday, August 22, 2023.

Applied BioMath announced they have been awarded a grant to develop a simulation platform to facilitate the prediction of optimal dose, therapeutic window, and best dosing strategy of Immunocytokines.